📰 Rob Iannone News
Page 3 - Rob Iannone News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rob Iannone. Real-time updates on events, politics, business and more.
June 3, 2023
Results presented today at ASCO 2023 and concurrently published in The Lancet Oncology demonstrate meaningful clinical benefit including antitumor activity, confirmed objective response rate
June 2, 2023
Results presented today at ASCO 2023 and concurrently published in The Lancet Oncology demonstrate meaningful clinical benefit including antitumor activity,...
May 31, 2023
FN Media Group Presents USA News Group News Commentary VANCOUVER, BC, May 31, 2023 /PRNewswire/ -- USA News Group - With this year's Annual Meeting of the American Society of Clinical
May 31, 2023
/PRNewswire/ -- USA News Group - With this years Annual Meeting of the American Society of Clinical Oncology (ASCO 2023) less than 30 days away, theres...
May 25, 2023
Zanidatamab data to be featured in oral presentation at ASCO 2023 Webcast to follow on June 2, 2023 at 6:45 p.m. CT DUBLIN, May 25, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq:
May 25, 2023
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will host a webcast to review the zanidatamab biliary tract cancers (BTC) data being featured in an...
May 14, 2023
Operator: Good day, and thank you for standing by. Welcome to the Q1 2023 Jazz Pharmaceuticals Earnings Conference Call. [Operator Instructions].
May 10, 2023
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter of 2023, affirmed 2023 financial guidance and...
April 27, 2023
Data from multiple studies of investigational bispecific drug zanidatamab, including pivotal Phase 2 biliary tract cancers (BTC) trial results, demonstrate...
April 27, 2023
Data from multiple studies of investigational bispecific drug zanidatamab, including pivotal Phase 2 biliary tract cancers (BTC) trial results, demonstrate breakthrough HER2-targeted pan-tumor